Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: GHSG-AFM13 An Open-label, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase II open-label study of AFM13 in relapsed or refractory Hodgkin lymphoma has completed recruitment.
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: HD16 for Early Stage Hodgkin Lymphoma [Phase 3]
A Phase 3 trial update for HD16 in early-stage Hodgkin lymphoma is reported, with status not specified.
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma [Phase 2]
Phase 2 trial update on combining nivolumab and brentuximab vedotin in untreated Hodgkin lymphoma in older patients; the study is active-not…
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: To Decrease Fatigue With Light Therapy [Phase 3]
Phase 3 trial investigating light therapy to decrease fatigue in patients with Hodgkin lymphoma and diffuse large B-cell lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating Brentuximab Vedotin plus antibody-drug conjugate in non-bulky limited stage Hodgkin Lymphoma has completed with res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: The Clinical Trial of Chidamide+Decitabine+Camrelizumab Versus Decitabine+Camrelizumab in Anti-PD-1 Antibody Resistant Patients With Classical Hodgkin Lymphoma. [Phase 2]
Phase 2 trial evaluating chidamide + decitabine + camrelizumab versus decitabine + camrelizumab in anti-PD-1 resistant classical Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating adding chidamide to decitabine plus camrelizumab in patients with relapsed/refractory classical Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma [Phase 1, Phase 2]
A phase 1/2 trial evaluating pembrolizumab plus lenalidomide in relapsed Hodgkin and non-Hodgkin lymphoma was terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Camrelizumab Plus Decitabine in Anti-PD-1 Treatment-naive Patients With Relapsed/Refractory Classical Hodgkin Lymphoma [Phase 2, Phase 3]
A phase 2/3 trial is evaluating camrelizumab plus decitabine in patients with relapsed/refractory classical Hodgkin lymphoma who are PD-1 tr…
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating combination chemotherapy for advanced Hodgkin's lymphoma, completed.
-
CLINICAL_TRIALS trial_result · 2020-07-21Clinical Trial Update: Brentuximab Vedotin as Alternative to the Autologous Stem Cell Transplantation in Relapsed and Refractory Classical Hodgkin's Lymphoma (BASALT) [Phase 2]
Phase 2 trial evaluating Brentuximab Vedotin as an alternative to autologous stem cell transplantation in relapsed/refractory classical Hodg…
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) [Phase 1, Phase 2]
Phase 1/2 trial evaluating Brentuximab Vedotin in combination with Bendamustine for Hodgkin lymphoma and anaplastic large cell lymphoma. The…
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating autologous peripheral stem cell transplant in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin's Lymphoma [Phase 1, Phase 2]
A clinical trial evaluating the safety and efficacy of nivolumab plus bendamustine in relapsed/refractory Hodgkin's lymphoma has completed p…
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: Meloxicam vs Placebo for Mobilization [Phase 2]
Phase 2 trial comparing Meloxicam to placebo for mobilization in hematologic malignancies has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR [NA]
Clinical trial update on donor-derived humoral immunity and hematopoietic stem cell transplantation completed with posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease [Phase 3]
Phase 3 clinical trial update evaluating radiation therapy and chemotherapy in Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment [Phase 2]
Phase 2 trial update of combination chemotherapy in Hodgkin's disease or non-Hodgkin lymphoma not responding to prior treatment.
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: HD17 for Intermediate Stage Hodgkin Lymphoma [Phase 3]
A Phase 3 clinical trial update for HD17 in intermediate stage Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: JAK-inhibition in Recurrent Classical Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating JAK inhibition in recurrent classical Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma [Phase 3]
Phase 3 clinical trial evaluating combination chemotherapy in treating young patients with Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating combination chemotherapy and radiation therapy in young Hodgkin's lymphoma patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy in young male patients with Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating everolimus and lenalidomide in relapsed or refractory non-Hodgkin or Hodgkin lymphoma; results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS) [Phase 1]
Phase 1 trial update for avelumab in previously treated advanced classical Hodgkin's lymphoma (JAVELIN HODGKINS) has terminated with results…